Indoco Remedies
add_icon

Indoco Remedies

196.28
-3.73
(-1.86%)
Market Cap
1,810.64 Cr
PE Ratio
-15.83
Volume
41,573.00
Day High - Low
202.00 - 192.00
52W High-Low
349.80 - 188.06
ann
There are 1 new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,810.64 Cr
EPS
-8.46
PE Ratio
-15.83
PB Ratio
1.88
Book Value
106.15
EBITDA
104.70
Dividend Yield
0.10 %
Industry
Healthcare
Return on Equity
-7.65
Debt to Equity
0.78
Analyst Rating and Forecast
- By Refinitiv from4 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+75.00 %
+75.00 %
Sell
Sell+25.00 %
+25.00 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Indoco Remedies' senior management will participate in the 11th Annual Valorem Conference on March 23, 2026, at Grand Hyatt, Santacruz (East) at 09:00 am.
positive
Indoco Remedies receives final USFDA approval for Brivaracetam Oral Solution, expanding its pharmaceutical portfolio in the US market with this anti-epileptic medication.
neutral
Indoco Remedies reported 6.8% revenue growth in Q3 FY26 with improved international business performance, though domestic formulations remained flat amid acute therapy challenges.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-8.58 %
Net Income Growth
-180.41 %
Cash Flow Change
-38.91 %
ROE
-187.53 %
ROCE
-104.41 %
EBITDA Margin (Avg.)
-54.92 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
213
237
249
250
248
287
284
264
267
324
334
297
382
374
349
401
396
405
412
429
417
478
461
462
425
432
404
386
433
473
435
Expenses
206
224
238
224
230
260
255
239
227
268
272
250
300
300
285
329
337
345
337
363
365
410
405
401
384
392
399
391
422
442
420
EBITDA
7
13
11
26
18
27
30
25
40
56
62
47
82
74
65
72
60
60
74
66
52
68
56
61
42
40
6
-5
10
30
15
Operating Profit %
3 %
5 %
4 %
9 %
7 %
9 %
10 %
9 %
15 %
17 %
18 %
15 %
21 %
19 %
18 %
18 %
15 %
15 %
18 %
15 %
12 %
13 %
12 %
9 %
10 %
9 %
1 %
-2 %
2 %
6 %
3 %
Depreciation
17
18
18
20
17
18
18
18
19
19
17
19
22
20
19
18
20
16
17
18
20
21
24
26
28
29
29
29
30
32
32
Interest
7
5
4
5
6
5
7
8
6
6
6
5
4
3
4
3
4
5
7
9
8
8
10
12
14
18
16
18
26
25
26
Profit Before Tax
-12
-10
4
9
-0
10
11
8
24
37
38
34
61
65
51
60
48
67
38
39
34
46
23
33
7
-5
-31
-46
-37
-14
-31
Tax
0
-3
-1
-2
-2
2
2
2
7
11
12
9
22
23
18
19
10
18
10
13
10
11
7
11
5
5
-3
-4
-0
-4
-2
Net Profit
-12
-7
5
12
2
8
9
5
17
26
25
25
40
42
33
41
39
50
28
26
24
35
16
22
2
-10
-28
-41
-36
-9
-30
EPS in ₹
-1.32
-0.81
0.57
1.25
0.20
0.85
0.99
0.58
1.85
2.78
2.75
2.71
4.30
4.52
3.58
4.39
4.19
5.40
3.05
2.80
2.62
3.82
1.69
2.39
0.20
-1.09
-3.08
-4.48
-3.94
-1.00
-3.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
846
941
1,197
1,236
1,258
1,272
1,315
1,486
1,658
2,145
2,430
Fixed Assets
340
374
440
489
468
590
570
555
678
954
997
Current Assets
385
465
572
537
538
563
623
774
814
955
1,001
Capital Work in Progress
63
55
91
136
185
51
68
122
114
125
321
Investments
0
16
0
0
0
0
0
0
3
9
2
Other Assets
443
496
666
612
605
631
677
809
864
1,057
1,111
Total Equity & Liabilities
846
941
1,197
1,236
1,258
1,272
1,315
1,486
1,658
2,145
2,430
Current Liabilities
262
303
390
416
446
459
407
425
425
612
808
Non Current Liabilities
65
61
155
146
152
133
139
157
205
422
604
Total Equity
519
577
651
675
661
680
769
905
1,028
1,111
1,018
Reserve & Surplus
500
558
633
657
642
661
751
886
1,010
1,092
1,004
Share Capital
18
18
18
18
18
18
18
18
18
18
18

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-0
50
-52
12
3
-14
8
-7
4
-3
Investing Activities
-88
-111
-171
-135
-104
-56
-67
-121
-208
-432
-339
Operating Activities
109
112
89
123
132
123
82
174
179
155
95
Financing Activities
-20
-2
132
-39
-16
-64
-30
-44
23
280
241

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.69 %
58.74 %
58.74 %
58.72 %
58.75 %
58.75 %
58.80 %
58.90 %
58.90 %
58.90 %
58.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
0.12 %
1.59 %
1.69 %
1.91 %
1.47 %
1.70 %
1.25 %
1.24 %
1.22 %
1.25 %
1.10 %
DIIs
18.88 %
18.80 %
17.22 %
17.23 %
17.64 %
17.52 %
17.33 %
18.07 %
17.29 %
17.78 %
19.56 %
19.41 %
18.67 %
18.24 %
18.90 %
18.75 %
18.96 %
18.16 %
18.15 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.92 %
15.92 %
17.32 %
17.87 %
17.87 %
17.23 %
16.85 %
16.74 %
16.48 %
16.84 %
15.24 %
15.33 %
16.29 %
16.30 %
16.07 %
15.99 %
15.79 %
16.40 %
16.48 %
Others
6.52 %
6.59 %
6.78 %
6.21 %
5.80 %
6.57 %
7.13 %
6.39 %
7.42 %
5.04 %
4.77 %
4.62 %
4.81 %
5.01 %
4.99 %
5.12 %
5.14 %
5.29 %
5.38 %
No of Share Holders
21,508
24,518
34,746
37,279
37,863
38,498
38,072
35,713
34,731
36,588
32,600
33,201
34,511
34,416
34,676
34,497
33,129
33,319
32,659

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1.6 1 0.3 0.3 1.5 2.25 2.25 1.5 0.2 0.00
Dividend Yield (%) 0.75 0.49 0.14 0.1 0.4 0.69 0.68 0.64 0.1 0.00

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 09, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2026
Financial Results For The Quarter And Nine Months Ended 31St December 2025Feb 03, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 03/02/2026Feb 03, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 03, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 20, 2026
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 16, 2026
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011Jan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Closure of Trading WindowDec 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 29, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Dec 19, 2025
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011Dec 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 11, 2025
Retirement Of Senior Management PersonnelNov 28, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 28, 2025
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Nov 28, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Nov 18, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Nov 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2025
Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th November 2025Nov 06, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Corporate Guarantee For Warren Remedies Private Limited Wholly Owned Subsidiary Of The CompanyOct 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 17, 2025
Clarification To BSE- Movement In VolumeOct 14, 2025
Clarification sought from Indoco Remedies LtdOct 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Reg 29 Of SEBI (LODR) Regulations 2015Oct 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Closure of Trading WindowSep 30, 2025
Announcement under Regulation 30 (LODR)-Credit RatingSep 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 12, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 11, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 14, 2025
Reg. 34 (1) Annual Report.Aug 14, 2025

Mutual Fund Holdings

Technical Indicators

RSI(14)
Neutral
41.54
ATR(14)
Volatile
8.31
STOCH(9,6)
Neutral
39.76
STOCH RSI(14)
Neutral
57.86
MACD(12,26)
Bullish
0.45
ADX(14)
Weak Trend
12.47
UO(9)
Bearish
43.41
ROC(12)
Downtrend And Accelerating
-3.36
WillR(14)
Neutral
-68.54